Veru Inc. VERU
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +2.34%
- 1 year
- -27.24%
- Open
- 2.25
- Prev close
- 2.23
- Mkt cap
- 37.34M
- Vol
- 78.95K
- Avg vol
- 221.21K
- EPS
- -0.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.16
- High
- 2.26
- Forward P/E
- -2.23
- Beta
- -0.46
- Short ratio
- 13.35
- Inst. own
- 42.04%
- Dividend
- 0.00
- Ex-div date
- Apr 27, 2014
- 50-d avg
- 0.7422
- 200-d avg
- 0.90395
- 1y target
- 3.40
Discussion (327)
Sign in to join the discussion
Buying pressure
I’m just hoping for VERU to reach anywhere near the Zach’s estimate of 3.40
Merge is happening October 9 don’t miss it
Visionary Education Technology Holdings Group Inc. Will Be Changing Its Ticker Symbol From "VEDU" To "GV". Effective When The Market Opens On Monday, October 9, 2023
Benzinga
·
10/02 16:01
1min
Veru Inc(VERU.US)
0.780
+2.23%
Visionary Education Technology(VEDU.US)
0.188
+12.68%
Visionary Education Technology Holdings Group Inc. (the "Company") (NASDAQ:VEDU), a private education provider located in Canada, with subsidiaries in Canada and market partners in China, today announced that it will be changing its ticker symbol from "VEDU" to "GV". Effective when the market opens on Monday, October 9, 2023, its common shares will trade on NASDAQ under the new ticker symbol "GV".
No action by the Company's shareholders is required with respect to the ticker symbol change. The Company's common shares will continue to be listed on NASDAQ and its CUSIP number will remain unchanged.
This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investm
Visionary Education Technology: Registration statement for securities of certain Canadian issuers (Amendment)
SEC announcement
·
03/25/2022 08:22
Visionary Education Technology(VEDU.US)
0.194
+16.03%
This announcement includes 6 separate documents:
Doc 1: View Original
Doc 2: View Original
Doc 3: View Original
Doc 4: View Original
Doc 5: View Original
Doc 6: View Original
This presentation is for informationa
MIAMI, FL, April 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related diseases, today announced the sale of its ENTADFI® (finasteride and tadalafil) capsules business for benign prostatic hyperplasia (BPH) to Blue Water Vaccines, Inc. (NASDAQ:BWV) for $20 million and up to an additional $80 million from sales milestones. Under the terms of the agreement, Veru received $6 million at closing and Blue Water is obligated to pay the Company an additional $4 million in the Company's fiscal year 2023, and an additional $10 million in installments in the Company's fiscal year 2024. In addition, Veru could receive up to an additional $80 million if certain ENTADFI sales milestones are achieved.
Account
VERU SELLS ENTADFI® BUSINESS FOR $20 MILLION PLUS UP TO AN ADDITIONAL $80 MILLION FROM SALES MILESTONES
04/20/2023 6:45AM
Veru Sells ENTADFI® Business for $20